Elderberry diet improves gut-brain axis dysfunction, neuroinflammation, and cognitive impairment in the rat model of irritable bowel syndrome.
Astrocyte
Elderberry
Gut-brain axis
Hippocampus
Irritable bowel syndrome
Journal
Metabolic brain disease
ISSN: 1573-7365
Titre abrégé: Metab Brain Dis
Pays: United States
ID NLM: 8610370
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
24
10
2022
accepted:
13
02
2023
medline:
17
5
2023
pubmed:
7
3
2023
entrez:
6
3
2023
Statut:
ppublish
Résumé
Irritable bowel syndrome (IBS) is related to a problem in the gut-brain axis. This experimental research aimed to shed light on the potential therapeutic application of elderberry (EB), which can work on the axis and get better the IBS symptoms. There were three groups (36 Sprague-Dawley rats) in this experiment, including control, IBS, and IBS with EB diet (IBS + EB). Making use of intracolonic instillation of 1 ml of 4% acetic acid for 30 s, IBS was induced. 7 days later, the EB extract (2%) was added to the diets of all animals for 8 weeks. Some histological, behavioral, and stereological techniques were used to detect the effects of EB on the gut and brain tissues. The findings showed that the EB diet improved locomotion and decreased anxiety-like behavior in the rat models of IBS. Moreover, the diet dropped the expression of TNF-α and increased mucosal layer thickness and the number of goblet and mast cells in colon tissue samples. In the hippocampal samples, administration of EB prevented astrogliosis and astrocyte reactivity. Although hippocampal and cortical neurons decreased markedly in the IBS group, EB prevented the drop in the number of neurons. Although lots of research is needed to elucidate the effectiveness of EB in IBS and its exact molecular mechanism, the result of this study showed that EB as an antioxidant and immune-modulatory agent could be a promising research target to prevent the impairment in the gut-brain axis, and could ameliorative classic IBS symptoms.
Identifiants
pubmed: 36877342
doi: 10.1007/s11011-023-01187-6
pii: 10.1007/s11011-023-01187-6
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1555-1572Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Amaral F, Sachs D, Costa V, Fagundes C, Cisalpino D, Cunha T, Ferreira S, Cunha F, Silva T, Nicoli J (2008) Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A 105:2193–2197. https://doi.org/10.1073/pnas.0711891105
doi: 10.1073/pnas.0711891105
pubmed: 18268332
pmcid: 2538897
Anjaneyulu M, Chopra K, Kaur I (2003) Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J Med Food 6:391–395. https://doi.org/10.1089/109662003772519976
doi: 10.1089/109662003772519976
pubmed: 14977450
Badescu M, Badulescu O, Badescu L, Ciocoiu M (2015) Effects of Sambucus nigra and Aronia melanocarpa extracts on immune system disorders within diabetes mellitus. Pharm Biol 53:533–539. https://doi.org/10.3109/13880209.2014.931441
doi: 10.3109/13880209.2014.931441
pubmed: 25327310
Balestra B, Vicini R, Cremon C, Zecchi L, Dothel G, Vasina V, De Giorgio R, Paccapelo A, Pastoris O, Stanghellini V (2012) Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons. Neurogastroenterol Motil 24:1118-e1570. https://doi.org/10.1111/nmo.12000
doi: 10.1111/nmo.12000
pubmed: 22937879
Barak V, Halperin T, Kalickman I (2001) The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines. Eur Cytokine Netw 12:290–296
pubmed: 11399518
Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW (2004) Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126:693–702. https://doi.org/10.1053/j.gastro.2003.11.055
doi: 10.1053/j.gastro.2003.11.055
pubmed: 14988823
Barbara G, Wang B, Stanghellini V, De Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M (2007) Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132:26–37. https://doi.org/10.1053/j.gastro.2006.11.039
doi: 10.1053/j.gastro.2006.11.039
pubmed: 17241857
Bercik P, Collins S, Verdu E (2012) Microbes and the gut-brain axis. Neurogastroenterol Motil 24:405–413. https://doi.org/10.1111/j.1365-2982.2012.01906.x
doi: 10.1111/j.1365-2982.2012.01906.x
pubmed: 22404222
Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G (2011) Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479:538–541. https://doi.org/10.1038/nature10554
doi: 10.1038/nature10554
pubmed: 22031325
Bischoff SC, Krämer S (2007) Human mast cells, bacteria, and intestinal immunity. Immunol Rev 217:329–337. https://doi.org/10.1111/j.1600-065x.2007.00523.x
doi: 10.1111/j.1600-065x.2007.00523.x
pubmed: 17498069
Boroujeni ME, Simani L, Bluyssen HA, Samadikhah HR, Zamanlui Benisi S, Hassani S, Akbari Dilmaghani N, Fathi M, Vakili K, Mahmoudiasl G-R (2021) Inflammatory response leads to neuronal death in human post-mortem cerebral cortex in patients with COVID-19. ACS Chem Neurosci. https://doi.org/10.1021/acschemneuro.1c00111
doi: 10.1021/acschemneuro.1c00111
pubmed: 34100287
Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H (2009) Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 137:1425–1434. https://doi.org/10.1053/j.gastro.2009.07.005
doi: 10.1053/j.gastro.2009.07.005
pubmed: 19596012
Bundy R, Walker AF, Middleton RW, Booth J (2004) Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. J Altern Complement Med 10:1015–1018. https://doi.org/10.1089/acm.2004.10.1015
doi: 10.1089/acm.2004.10.1015
pubmed: 15673996
Butt AS, Salih M, Jafri W, Yakoob J, Wasay M, Hamid S (2012) Irritable bowel syndrome and psychiatric disorders in Pakistan: a case control study. Gastroenterol Res Pract 2012. https://doi.org/10.1155/2012/291452
Camilleri M (2013) Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opin Pharmacother 14:1151–1160. https://doi.org/10.1517/14656566.2013.794223
doi: 10.1517/14656566.2013.794223
pubmed: 23621801
Camilleri M, McKinzie S, Busciglio I, Low PA, Sweetser S, Burton D, Baxter K, Ryks M, Zinsmeister AR (2008) Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 6:772–781. https://doi.org/10.1016/j.cgh.2008.02.060
doi: 10.1016/j.cgh.2008.02.060
pubmed: 18456567
pmcid: 2495078
Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C (2017) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49:60–68. https://doi.org/10.1016/j.neurobiolaging.2016.08.019
doi: 10.1016/j.neurobiolaging.2016.08.019
pubmed: 27776263
Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P, Steinhoff M, Barbara G, Beck P, Bunnett NW (2007) Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 117:636–647. https://doi.org/10.1172/jci29255
doi: 10.1172/jci29255
pubmed: 17304351
pmcid: 1794118
Chen P-C, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA (2009) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson’s disease: critical role for the astrocyte. Proc Natl Acad Sci U S A 106:2933–2938. https://doi.org/10.1073/pnas.0813361106
doi: 10.1073/pnas.0813361106
pubmed: 19196989
pmcid: 2650368
Chitkara DK, van Tilburg MA, Blois-Martin N, Whitehead WE (2008) Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol 103. https://doi.org/10.1111/j.1572-0241.2007.01722.x
Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, Stanghellini V, Grundy D, Tonini M, De Ponti F (2011) Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol 106:1290–1298. https://doi.org/10.1038/ajg.2011.86
doi: 10.1038/ajg.2011.86
pubmed: 21427712
Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13:701–712. https://doi.org/10.1038/nrn3346
doi: 10.1038/nrn3346
pubmed: 22968153
Davis BM, Salinas-Navarro M, Cordeiro MF, Moons L, De Groef L (2017) Characterizing microglia activation: a spatial statistics approach to maximize information extraction. Sci Rep 7:1–12. https://doi.org/10.1038/s41598-017-01747-8
doi: 10.1038/s41598-017-01747-8
de Rus Jacquet A, Timmers M, Ma SY, Thieme A, McCabe GP, Vest JHC, Lila MA, Rochet J-C (2017) Lumbee traditional medicine: neuroprotective activities of medicinal plants used to treat Parkinson’s disease-related symptoms. J Ethnopharmacol 206:408–425. https://doi.org/10.1016/j.jep.2017.02.021
doi: 10.1016/j.jep.2017.02.021
pubmed: 28214539
pmcid: 6149226
de Vries HE, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J, van Horssen J (2008) Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med 45:1375–1383. https://doi.org/10.1016/j.freeradbiomed.2008.09.001
doi: 10.1016/j.freeradbiomed.2008.09.001
pubmed: 18824091
Drossman DA (2006) The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130:1377–1390. https://doi.org/10.1053/j.gastro.2006.03.008
Farzaneh N, Ghobakhlou M, Moghimi-Dehkordi B, Naderi N, Fadai F (2012) Evaluation of psychological aspects among subtypes of irritable bowel syndrome. Indian J Psychol Med 34:144–148. https://doi.org/10.4103/0253-7176.101780
doi: 10.4103/0253-7176.101780
pubmed: 23162190
pmcid: 3498777
Ferreira SS, Martins-Gomes C, Nunes FM, Silva AM (2022) Elderberry (Sambucus nigra L.) extracts promote anti-inflammatory and cellular antioxidant activity. Food Chem: X 15:100437
pubmed: 36211754
Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J, Roger M, Tamouza R, Leboyer M, Boyer L (2014) Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 264:651–660. https://doi.org/10.1007/s00406-014-0502-z
doi: 10.1007/s00406-014-0502-z
pubmed: 24705634
Gan L, Vargas MR, Johnson DA, Johnson JA (2012) Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model. J Neurosci 32:17775–17787. https://doi.org/10.1523/jneurosci.3049-12.2012
doi: 10.1523/jneurosci.3049-12.2012
pubmed: 23223297
pmcid: 3539799
Giannini EG, Mansi C, Dulbecco P, Savarino V (2006) Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition 22:334–342. https://doi.org/10.1016/j.nut.2005.10.003
doi: 10.1016/j.nut.2005.10.003
pubmed: 16413751
Gray AM, Abdel-Wahab YH, Flatt PR (2000) The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitro. J Nutr 130:15–20. https://doi.org/10.1093/jn/130.1.15
doi: 10.1093/jn/130.1.15
pubmed: 10613759
Guilarte M, Santos J, De Torres I, Alonso C, Vicario M, Ramos L, Martínez C, Casellas F, Saperas E, Malagelada JR (2007) Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 56:203–209. https://doi.org/10.1136/gut.2006.100594
doi: 10.1136/gut.2006.100594
pubmed: 17005763
Guven B, Can M, Piskin O, Aydin BG, Karakaya K, Elmas O, Acikgoz B (2019) Flavonoids protect colon against radiation induced colitis. Regul Toxicol Pharmacol 104:128–132. https://doi.org/10.1016/j.yrtph.2019.03.006
doi: 10.1016/j.yrtph.2019.03.006
pubmed: 30878575
Gyoneva S, Davalos D, Biswas D, Swanger SA, Garnier-Amblard E, Loth F, Akassoglou K, Traynelis SF (2014) Systemic inflammation regulates microglial responses to tissue damage in vivo. Glia 62:1345–1360. https://doi.org/10.1002/glia.22686
doi: 10.1002/glia.22686
pubmed: 24807189
pmcid: 4408916
Hawrelak JA, Myers SP (2010) Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study. J Altern Complement Med 16:1065–1071. https://doi.org/10.1089/acm.2009.0090
doi: 10.1089/acm.2009.0090
pubmed: 20954962
Héron A, Dubayle D (2013) A focus on mast cells and pain. J Neuroimmunol 264:1–7. https://doi.org/10.1016/j.jneuroim.2013.09.018
doi: 10.1016/j.jneuroim.2013.09.018
pubmed: 24125568
Jang H, Ha U-S, Kim S-J, Yoon B-I, Han D-S, Yuk S-M, Kim S-W (2010) Anthocyanin extracted from black soybean reduces prostate weight and promotes apoptosis in the prostatic hyperplasia-induced rat model. J Agric Food Chem 58:12686–12691
doi: 10.1021/jf102688g
pubmed: 21121678
Kennedy P, Cryan J, Quigley E, Dinan T, Clarke G (2014) A sustained hypothalamic–pituitary–adrenal axis response to acute psychosocial stress in irritable bowel syndrome. Psychol Med 44:3123–3134. https://doi.org/10.1017/s003329171400052x
doi: 10.1017/s003329171400052x
pubmed: 25065954
Kennedy PJ, Clarke G, Quigley EM, Groeger JA, Dinan TG, Cryan JF (2012) Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev 36:310–340. https://doi.org/10.1016/j.neubiorev.2011.07.001
doi: 10.1016/j.neubiorev.2011.07.001
pubmed: 21777613
Kilpatrick LA, Gupta A, Love AD, Labus JS, Alaverdyan M, Tillisch K, Naliboff BD, Mayer EA (2015) Mo2030 neurobiology of psychological resilience in Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) patients. Gastroenterology 148:S-774. https://doi.org/10.1016/S0016-5085%2815%2932639-1
Klooker TK, Braak B, Koopman KE, Welting O, Wouters MM, van der Heide S, Schemann M, Bischoff SC, van den Wijngaard RM, Boeckxstaens GE (2010) The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 59:1213–1221. https://doi.org/10.1136/gut.2010.213108
doi: 10.1136/gut.2010.213108
pubmed: 20650926
Klooker TK, Braak B, Painter RC, De Rooij SR, Van Elburg RM, Van Den Wijngaard RM, Roseboom TJ, Boeckxstaens GE (2009) Exposure to severe wartime conditions in early life is associated with an increased risk of irritable bowel syndrome: a population-based cohort study. Am J Gastroenterol 104:2250–2256. https://doi.org/10.1038/ajg.2009.282
doi: 10.1038/ajg.2009.282
pubmed: 19513027
Knowles SR, Austin DW, Sivanesan S, Tye-Din J, Leung C, Wilson J, Castle D, Kamm MA, Macrae F, Hebbard G (2017) Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness. Psychol Health Med 22:524–534. https://doi.org/10.1080/13548506.2016.1168932
doi: 10.1080/13548506.2016.1168932
pubmed: 27045996
Krammer L, Sowa AS, Lorentz A (2019) Mast cells in irritable bowel syndrome: a systematic review. J Gastrointest Liver Dis 28. https://doi.org/10.15403/jgld-229
Kumar H, Kim I-S, More SV, Kim B-W, Choi D-K (2014) Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Nat Prod Rep 31:109–139. https://doi.org/10.1039/c3np70065h
doi: 10.1039/c3np70065h
pubmed: 24292194
Kumar H, Koppula S, Kim I-S, Vasant More S, Kim B-W, Choi D-K (2012) Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death. CNS Neurol Disord Drug Targets 11:1015–1029. https://doi.org/10.2174/1871527311211080012
doi: 10.2174/1871527311211080012
pubmed: 23244425
Lamy S, Muhire É, Annabi B (2018) Antiproliferative efficacy of elderberries and elderflowers (Sambucus canadensis) on glioma and brain endothelial cells under normoxic and hypoxic conditions. J Funct Foods 40:164–179
doi: 10.1016/j.jff.2017.10.048
Langhammer CG, Previtera ML, Sweet ES, Sran SS, Chen M, Firestein BL (2010) Automated Sholl analysis of digitized neuronal morphology at multiple scales: whole cell Sholl analysis versus Sholl analysis of arbor subregions. Cytometry Part A 77:1160–1168. https://doi.org/10.1002/cyto.a.20954
doi: 10.1002/cyto.a.20954
Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, Creed F (2006) Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 130:1447–1458. https://doi.org/10.1016/s0889-8553(05)70363-0
doi: 10.1016/s0889-8553(05)70363-0
pubmed: 16678558
Liu JP, Yang M, Liu Y, Wei ML, Grimsgaard S (2006) Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd004116.pub2
doi: 10.1002/14651858.cd004116.pub2
pubmed: 17054239
pmcid: 8865522
López-Gómez L, Bagüés A, Uranga JA, Abalo R (2020) Preclinical models of irritable bowel syndrome. A comprehensive overview of irritable bowel syndrome. Elsevier, 233–276
Mahmoudi M, Ebrahimzadeh M, Dooshan A, Arimi A, Ghasemi N, Fathiazad F (2014) Antidepressant activities of Sambucus ebulus and Sambucus nigra. Eur Rev Med Pharmacol Sci 18:3350–3353
pubmed: 25491608
Manocha GD, Floden AM, Miller NM, Smith AJ, Nagamoto-Combs K, Saito T, Saido TC, Combs CK (2019) Temporal progression of Alzheimer’s disease in brains and intestines of transgenic mice. Neurobiol Aging 81:166–176. https://doi.org/10.1016/j.neurobiolaging.2019.05.025
doi: 10.1016/j.neurobiolaging.2019.05.025
pubmed: 31284126
pmcid: 6732235
Mao Y (2016) Nearest neighbor distances calculation with ImageJ. Journal
Martin CR, Osadchiy V, Kalani A, Mayer EA (2018) The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol 6:133–148
doi: 10.1016/j.jcmgh.2018.04.003
pubmed: 30023410
pmcid: 6047317
Mayer EA (2011) Gut feelings: the emerging biology of gut–brain communication. Nat Rev Neurosci 12:453–466. https://doi.org/10.1038/nrn3071
doi: 10.1038/nrn3071
pubmed: 21750565
Mayer EA, Naliboff BD, Chang L, Coutinho SV (2001) Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 280:G519-G524. https://doi.org/10.1152/ajpgi.2001.280.4.g519
Mikulic-Petkovsek M, Ivancic A, Todorovic B, Veberic R, Stampar F (2015) Fruit phenolic composition of different elderberry species and hybrids. J Food Sci 80:C2180–C2190. https://doi.org/10.1111/1750-3841.13008
doi: 10.1111/1750-3841.13008
pubmed: 26409176
Moghaddam MH, Bayat A-H, Eskandari N, Abdollahifar M-a, Fotouhi F, Forouzannia A, Rafiei R, Hatari S, Seraj A, Shahidi AMEJ (2021) Elderberry diet ameliorates motor function and prevents oxidative stress-induced cell death in rat models of Huntington disease. Brain Res 1762:147444. https://doi.org/10.1016/j.brainres.2021.147444
doi: 10.1016/j.brainres.2021.147444
pubmed: 33745925
Moghaddam MH, Farrokhi S, Hasani A, Khosravi A, Pirani M, Vakili K, Fathi M, Eskandari N, Golshan A, Sadeghzadeh S, Namakin K, Aliaghaei A, Abdollahifar M-A (2022) Elderberry diet restores spermatogenesis in the transient Scrotal Hyperthermia-Induced mice. Reprod Sci 29:3373–3386. https://doi.org/10.1007/s43032-022-00865-7
doi: 10.1007/s43032-022-00865-7
pubmed: 35088364
Moloney RD, Johnson AC, O’mahony SM, Dinan TG, Greenwood-Van Meerveld B, Cryan JF (2016) Stress and the microbiota–gut–brain axis in visceral pain: relevance to irritable bowel syndrome. CNS Neurosci Ther 22:102–117. https://doi.org/10.1111/cns.12490
doi: 10.1111/cns.12490
pubmed: 26662472
Moser G, Fournier C, Peter J (2018) Intestinal microbiome-gut-brain axis and irritable bowel syndrome. Wien Med Wochenschr 168:62–66. https://doi.org/10.1007/s10354-017-0592-0
doi: 10.1007/s10354-017-0592-0
pubmed: 28887729
Mota AH, Duarte N, Serra AT, Ferreira A, Bronze MR, Custódio L, Gaspar MM, Simões S, Rijo P, Ascensão L (2020) Further evidence of possible therapeutic uses of Sambucus nigra L. extracts by the assessment of the in vitro and in vivo anti-inflammatory properties of its PLGA and PCL-based nanoformulations. Pharmaceutics 12:1181. https://doi.org/10.3390/pharmaceutics12121181
doi: 10.3390/pharmaceutics12121181
pubmed: 33291738
pmcid: 7761993
Muscatello MRA, Bruno A, Pandolfo G, Mico U, Stilo S, Scaffidi M, Consolo P, Tortora A, Pallio S, Giacobbe G (2010) Depression, anxiety and anger in subtypes of irritable bowel syndrome patients. J Clin Psychol Med Settings 17:64–70. https://doi.org/10.1007/s10880-009-9182-7
doi: 10.1007/s10880-009-9182-7
pubmed: 20094761
Netzel M, Strass G, Herbst M, Dietrich H, Bitsch R, Bitsch I, Frank T (2005) The excretion and biological antioxidant activity of elderberry antioxidants in healthy humans. Food Res Int 38:905–910. https://doi.org/10.1016/j.foodres.2005.03.010
doi: 10.1016/j.foodres.2005.03.010
O’sullivan M, Clayton N, Breslin N, Harman I, Bountra C, McLaren A, O’Morain C (2000) Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 12:449–458. https://doi.org/10.1046/j.1365-2982.2000.00221.x
doi: 10.1046/j.1365-2982.2000.00221.x
pubmed: 11012945
Öhman L, Simrén M (2010) Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 7:163–173. https://doi.org/10.1038/nrgastro.2010.4
doi: 10.1038/nrgastro.2010.4
pubmed: 20101257
Park A, Collins J, Blennerhassett P, Ghia J, Verdu E, Bercik P, Collins S (2013) Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol Motil 25:733-e575. https://doi.org/10.1111/nmo.12153
doi: 10.1111/nmo.12153
pubmed: 23773726
pmcid: 3912902
Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR (2012) Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 143:1179–1187. https://doi.org/10.1053/j.gastro.2012.08.002
doi: 10.1053/j.gastro.2012.08.002
pubmed: 22885331
Pellissier S, Dantzer C, Mondillon L, Trocme C, Gauchez A-S, Ducros V, Mathieu N, Toussaint B, Fournier A, Canini F (2014) Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn’s disease and irritable bowel syndrome. PLoS ONE 9:e105328. https://doi.org/10.1371/journal.pone.0105328
doi: 10.1371/journal.pone.0105328
pubmed: 25207649
pmcid: 4160179
Portincasa P, Bonfrate L, Scribano ML, Kohn A, Caporaso N, Festi D, Campanale MC, Di Rienzo T, Guarino M, Taddia M (2016) Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome. J Gastrointest Liver Dis 25. https://doi.org/10.15403/jgld.2014.1121.252.ccm
Raskov H, Burcharth J, Pommergaard H-C, Rosenberg J (2016) Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut microbes 7:365–383
doi: 10.1080/19490976.2016.1218585
pubmed: 27472486
pmcid: 5046167
Rhee SH, Pothoulakis C, Mayer EA (2009) Principles and clinical implications of the brain–gut–enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6:306–314. https://doi.org/10.1038/nrgastro.2009.35
doi: 10.1038/nrgastro.2009.35
pubmed: 19404271
Rugină D, Hanganu D, Diaconeasa Z, Tăbăran F, Coman C, Leopold L, Bunea A, Pintea A (2017) Antiproliferative and apoptotic potential of cyanidin-based anthocyanins on melanoma cells. Int J Mol Sci 18:949
doi: 10.3390/ijms18050949
pubmed: 28468289
pmcid: 5454862
Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell 167:1469–1480. https://doi.org/10.1016/j.cell.2016.11.018
doi: 10.1016/j.cell.2016.11.018
pubmed: 27912057
pmcid: 5718049
Santos J, Guilarte M, Alonso C, Malagelada J (2005) Pathogenesis of irritable bowel syndrome: the mast cell connection. Scand J Gastroenterol 40:129–140. https://doi.org/10.1080/00365520410009410
doi: 10.1080/00365520410009410
pubmed: 15764142
Satoh T, McKercher SR, Lipton SA (2013) Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radic Biol Med 65:645–657. https://doi.org/10.1016/j.freeradbiomed.2013.07.022
doi: 10.1016/j.freeradbiomed.2013.07.022
pubmed: 23892355
Semar S, Klotz M, Letiembre M, Van Ginneken C, Braun A, Jost V, Bischof M, Lammers WJ, Liu Y, Fassbender K (2013) Changes of the enteric nervous system in amyloid-β protein precursor transgenic mice correlate with disease progression. J Alzheimers Dis 36:7–20. https://doi.org/10.3233/jad-120511
doi: 10.3233/jad-120511
pubmed: 23531500
Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L, Hao Y, Gu Y, Han C (2020) New mechanism of neuroinflammation in Alzheimer’s disease: the activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuropsychopharmacol Biol Psychiatry 100:109884. https://doi.org/10.1016/j.pnpbp.2020.109884
doi: 10.1016/j.pnpbp.2020.109884
pubmed: 32032696
Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, Johnson JA, Murphy TH (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 23:3394–3406. https://doi.org/10.1523/jneurosci.23-08-03394.2003
doi: 10.1523/jneurosci.23-08-03394.2003
pubmed: 12716947
pmcid: 6742304
Shukla PK, Delotterie DF, Xiao J, Pierre JF, Rao R, McDonald MP, Khan MM (2021) Alterations in the gut-microbial-inflammasome-brain axis in a mouse model of Alzheimer’s disease. Cells 10:779. https://doi.org/10.3390/cells10040779
doi: 10.3390/cells10040779
pubmed: 33916001
pmcid: 8067249
Spanier JA, Howden CW, Jones MP (2003) A systematic review of alternative therapies in the irritable bowel syndrome. Arch Intern Med 163:265–274. https://doi.org/10.1001/archinte.163.3.265
doi: 10.1001/archinte.163.3.265
pubmed: 12578506
Stanculete MF, Matu S, Pojoga C, Dumitrascu DL (2015) Coping strategies and irrational beliefs as mediators of the health-related quality of life impairments in irritable bowel syndrome. J Gastrointest Liver Dis 24. https://doi.org/10.15403/jgld.2014.1121.242.strt
Stasi C, Rosselli M, Bellini M, Laffi G, Milani S (2012) Altered neuro-endocrine–immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol 47:1177–1185. https://doi.org/10.1007/s00535-012-0627-7
doi: 10.1007/s00535-012-0627-7
pubmed: 22766747
Sugaya N, Nomura S, Shimada H (2012) Relationship between cognitive factors and anxiety in individuals with irritable bowel syndrome. Int J Behav Med 19:308–315. https://doi.org/10.1007/s12529-011-9195-0
doi: 10.1007/s12529-011-9195-0
pubmed: 21935740
Tang QL, Lai ML, Zhong YF, Wang AM, Su JK, Zhang MQ (2013) Antinociceptive effect of berberine on visceral hypersensitivity in rats. World J Gastroenterol 19:4582–4589. https://doi.org/10.3748/wjg.v19.i28.4582
doi: 10.3748/wjg.v19.i28.4582
pubmed: 23901236
pmcid: 3725385
Tejera D, Mercan D, Sanchez-Caro JM, Hanan M, Greenberg D, Soreq H, Latz E, Golenbock D, Heneka MT (2019) Systemic inflammation impairs microglial Aβ clearance through NLRP 3 inflammasome. EMBO J 38:e101064. https://doi.org/10.15252/embj.2018101064
doi: 10.15252/embj.2018101064
pubmed: 31359456
pmcid: 6717897
Tiralongo E, Wee SS, Lea RA (2016) Elderberry supplementation reduces cold duration and symptoms in air-travellers: a randomized, double-blind placebo-controlled clinical trial. Nutrients 8:182. https://doi.org/10.3390/nu8040182
doi: 10.3390/nu8040182
pubmed: 27023596
pmcid: 4848651
Uranga JA, Martínez V, Abalo R (2020) Mast cell regulation and irritable bowel syndrome: Effects of food components with potential nutraceutical use. Molecules 25:4314. https://doi.org/10.3390/molecules25184314
doi: 10.3390/molecules25184314
pubmed: 32962285
pmcid: 7570512
Valdez-Morales EE, Overington J, Guerrero-Alba R, Ochoa-Cortes F, Ibeakanma CO, Spreadbury I, Bunnett NW, Beyak M, Vanner SJ (2013) Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. Am J Gastroenterol 108:1634–1643. https://doi.org/10.1038/ajg.2013.241
doi: 10.1038/ajg.2013.241
pubmed: 23958521
van Tilburg MA, Runyan DK, Zolotor AJ, Graham JC, Dubowitz H, Litrownik AJ, Flaherty E, Chitkara DK, Whitehead WE (2010) Unexplained gastrointestinal symptoms after abuse in a prospective study of children at risk for abuse and neglect. Ann Fam Med 8:134–140. https://doi.org/10.1370/afm.1053
doi: 10.1370/afm.1053
pubmed: 20212300
pmcid: 2834720
Varian BJ, Goureshetti S, Poutahidis T, Lakritz JR, Levkovich T, Kwok C, Teliousis K, Ibrahim YM, Mirabal S, Erdman SE (2016) Beneficial bacteria inhibit cachexia. Oncotarget 7:11803
doi: 10.18632/oncotarget.7730
pubmed: 26933816
pmcid: 4914249
Vuong HE, Hsiao EY (2017) Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry 81:411–423. https://doi.org/10.1016/j.biopsych.2016.08.024
doi: 10.1016/j.biopsych.2016.08.024
pubmed: 27773355
Wang S, Tanzi RE, Li A (2019) Quantitative analysis of neuronal dendritic arborization complexity in Drosophila. JoVE. https://doi.org/10.3791/57139
doi: 10.3791/57139
pubmed: 31929505
Wäussle H, Grüunert U, Röhrenbeck J (1993) Immunocytochemical staining of AII-amacrine cells in the rat retina with antibodies against parvalbumin. J Comp Neurol 332:407–420. https://doi.org/10.1002/cne.903320403
doi: 10.1002/cne.903320403
Wesolowski J, Paumet F (2011) The impact of bacterial infection on mast cell degranulation. Immunol Res 51:215–226. https://doi.org/10.1007/s12026-011-8250-x
doi: 10.1007/s12026-011-8250-x
pubmed: 22048902
Wood H (2018) Peripheral inflammation could be a prodromal indicator of dementia. Nat Rev Neurol 14:127–127. https://doi.org/10.1038/nrneurol.2018.8
doi: 10.1038/nrneurol.2018.8
pubmed: 29377009
Xu L, Yu W, Jiang J, Feng X, Li N (2015) Efficacy of pectin in the treatment of diarrhea predominant irritable bowel syndrome. Zhonghua wei Chang wai ke za zhi = Chinese. J Gastrointest Surg 18:267–271. https://doi.org/10.3760/CMA.J.ISSN.1671-0274.2015.03.015
doi: 10.3760/CMA.J.ISSN.1671-0274.2015.03.015
Zhang J, Wen C, Zhang H, Duan Y (2019) Review of isolation, structural properties, chain conformation, and bioactivities of psyllium polysaccharides. Int J Biol Macromol 139:409–420. https://doi.org/10.1016/j.ijbiomac.2019.08.014
doi: 10.1016/j.ijbiomac.2019.08.014
pubmed: 31381918
Zhang L, Song J, Hou X (2016) Mast cells and irritable bowel syndrome: from the bench to the bedside. J Neurogastroenterol Motil 22:181. https://doi.org/10.5056/jnm15137
doi: 10.5056/jnm15137
pubmed: 26755686
pmcid: 4819856